WGU D027 Advanced Pathopharmacological
Foundations ACTUAL EXAM 2026/2027 |
Advanced Practice Nursing | Verified Q&A |
Pass Guaranteed - A+ Graded
Section 1: Cellular Adaptation, Injury, & Neoplasia (10 Questions)
Q1: A 68-year-old male with a 40 pack-year smoking history presents with a persistent cough and
hemoptysis. Chest CT reveals a spiculated mass in the right upper lobe. Biopsy shows squamous cell
carcinoma with keratin pearls. Which cellular adaptation process most likely preceded the malignant
transformation in the bronchial epithelium?
A. Hypertrophy
B. Metaplasia
C. Hyperplasia
D. Dysplasia. [CORRECT]
Correct Answer: D
Rationale: Dysplasia is disordered, dysfunctional cellular growth characterized by loss of normal tissue
architecture and cellular polarity. In the respiratory tract, smoking-induced dysplasia of bronchial
epithelium represents a preneoplastic change that can progress through carcinoma in situ to invasive
squamous cell carcinoma, representing the classical multistep carcinogenesis pathway. [CORRECT]
Q2: A patient with chronic gastroesophageal reflux disease develops Barrett's esophagus. Which cellular
adaptation is occurring?
A. Atrophy
B. Metaplasia
C. Anaplasia
D. Apoptosis. [CORRECT]
Correct Answer: B
,Rationale: Barrett's esophagus is an example of metaplasia—replacement of normal squamous
epithelium with columnar epithelium containing goblet cells (intestinal metaplasia). This adaptive
change occurs in response to chronic acid exposure and represents a premalignant condition with
increased risk of adenocarcinoma. [CORRECT]
Q3: A patient receiving doxorubicin for breast cancer develops dose-dependent cardiomyopathy. Which
mechanism of cellular injury is primarily responsible?
A. Disruption of microtubule formation
B. Generation of free radicals and lipid peroxidation
C. Inhibition of DNA topoisomerase II
D. Blockade of estrogen receptors. [CORRECT]
Correct Answer: B
Rationale: Doxorubicin causes cardiotoxicity primarily through redox cycling and generation of reactive
oxygen species (ROS), particularly superoxide anion and hydroxyl radicals. These free radicals cause lipid
peroxidation of cardiac myocyte membranes, mitochondrial DNA damage, and disruption of calcium
handling, leading to cumulative, dose-dependent cardiomyopathy. [CORRECT]
Q4: A patient with chronic hepatitis C develops cirrhosis. Laboratory analysis reveals elevated serum
ferritin and transferrin saturation. Which mechanism of cellular injury is most likely contributing to the
liver damage?
A. Hypoxic injury
B. Iron-mediated free radical generation (Fenton reaction)
C. Apoptosis via Fas-Fas ligand pathway
D. Endoplasmic reticulum stress. [CORRECT]
Correct Answer: B
Rationale: Iron overload in hepatitis C promotes cellular injury through the Fenton reaction, where
ferrous iron (Fe²⁺) reacts with hydrogen peroxide to generate highly reactive hydroxyl radicals (•OH).
These radicals cause oxidative damage to hepatocyte membranes, proteins, and DNA, accelerating
fibrosis and increasing the risk of hepatocellular carcinoma. [CORRECT]
Q5: A 55-year-old female presents with a painless, firm, immobile breast mass. Biopsy reveals invasive
ductal carcinoma with overexpression of HER2/neu (ERBB2). Which targeted therapy mechanism is most
appropriate?
, A. Selective estrogen receptor modulation
B. Inhibition of HER2 tyrosine kinase receptor signaling
C. Blockade of vascular endothelial growth factor (VEGF)
D. Inhibition of cyclin-dependent kinases 4 and 6. [CORRECT]
Correct Answer: B
Rationale: HER2/neu (ERBB2) is a transmembrane tyrosine kinase receptor that drives cellular
proliferation, survival, and angiogenesis when overexpressed. Trastuzumab (Herceptin) is a monoclonal
antibody that binds the extracellular domain of HER2, preventing receptor dimerization and
downstream PI3K/AKT and RAS/MAPK signaling pathways, thereby inhibiting tumor growth and
promoting antibody-dependent cellular cytotoxicity. [CORRECT]
Q6: A patient with metastatic melanoma is treated with pembrolizumab. Which cellular mechanism
does this drug target?
A. Inhibition of BRAF V600E mutation
B. Blockade of programmed cell death protein 1 (PD-1)
C. Inhibition of MEK1/2 kinases
D. Blockade of cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). [CORRECT]
Correct Answer: B
Rationale: Pembrolizumab is a humanized monoclonal antibody that blocks the interaction between PD-
1 on T cells and its ligands PD-L1/PD-L2 on tumor cells. This checkpoint inhibition prevents T-cell
exhaustion and restores antitumor immunity, allowing cytotoxic T cells to recognize and kill melanoma
cells expressing tumor antigens. [CORRECT]
Q7: A patient with small cell lung cancer (SCLC) is treated with cisplatin and etoposide. Cisplatin exerts
its cytotoxic effect primarily through:
A. Inhibition of thymidylate synthase
B. Formation of DNA cross-links and activation of apoptotic pathways
C. Inhibition of microtubule polymerization
D. Blockade of androgen receptor signaling. [CORRECT]
Correct Answer: B
Rationale: Cisplatin is a platinum-based alkylating agent that enters cells through copper transporters,
becomes aquated in the cytoplasm, and forms covalent cross-links between adjacent guanine residues
in DNA. These intrastrand and interstrand cross-links block DNA replication and transcription, triggering
Foundations ACTUAL EXAM 2026/2027 |
Advanced Practice Nursing | Verified Q&A |
Pass Guaranteed - A+ Graded
Section 1: Cellular Adaptation, Injury, & Neoplasia (10 Questions)
Q1: A 68-year-old male with a 40 pack-year smoking history presents with a persistent cough and
hemoptysis. Chest CT reveals a spiculated mass in the right upper lobe. Biopsy shows squamous cell
carcinoma with keratin pearls. Which cellular adaptation process most likely preceded the malignant
transformation in the bronchial epithelium?
A. Hypertrophy
B. Metaplasia
C. Hyperplasia
D. Dysplasia. [CORRECT]
Correct Answer: D
Rationale: Dysplasia is disordered, dysfunctional cellular growth characterized by loss of normal tissue
architecture and cellular polarity. In the respiratory tract, smoking-induced dysplasia of bronchial
epithelium represents a preneoplastic change that can progress through carcinoma in situ to invasive
squamous cell carcinoma, representing the classical multistep carcinogenesis pathway. [CORRECT]
Q2: A patient with chronic gastroesophageal reflux disease develops Barrett's esophagus. Which cellular
adaptation is occurring?
A. Atrophy
B. Metaplasia
C. Anaplasia
D. Apoptosis. [CORRECT]
Correct Answer: B
,Rationale: Barrett's esophagus is an example of metaplasia—replacement of normal squamous
epithelium with columnar epithelium containing goblet cells (intestinal metaplasia). This adaptive
change occurs in response to chronic acid exposure and represents a premalignant condition with
increased risk of adenocarcinoma. [CORRECT]
Q3: A patient receiving doxorubicin for breast cancer develops dose-dependent cardiomyopathy. Which
mechanism of cellular injury is primarily responsible?
A. Disruption of microtubule formation
B. Generation of free radicals and lipid peroxidation
C. Inhibition of DNA topoisomerase II
D. Blockade of estrogen receptors. [CORRECT]
Correct Answer: B
Rationale: Doxorubicin causes cardiotoxicity primarily through redox cycling and generation of reactive
oxygen species (ROS), particularly superoxide anion and hydroxyl radicals. These free radicals cause lipid
peroxidation of cardiac myocyte membranes, mitochondrial DNA damage, and disruption of calcium
handling, leading to cumulative, dose-dependent cardiomyopathy. [CORRECT]
Q4: A patient with chronic hepatitis C develops cirrhosis. Laboratory analysis reveals elevated serum
ferritin and transferrin saturation. Which mechanism of cellular injury is most likely contributing to the
liver damage?
A. Hypoxic injury
B. Iron-mediated free radical generation (Fenton reaction)
C. Apoptosis via Fas-Fas ligand pathway
D. Endoplasmic reticulum stress. [CORRECT]
Correct Answer: B
Rationale: Iron overload in hepatitis C promotes cellular injury through the Fenton reaction, where
ferrous iron (Fe²⁺) reacts with hydrogen peroxide to generate highly reactive hydroxyl radicals (•OH).
These radicals cause oxidative damage to hepatocyte membranes, proteins, and DNA, accelerating
fibrosis and increasing the risk of hepatocellular carcinoma. [CORRECT]
Q5: A 55-year-old female presents with a painless, firm, immobile breast mass. Biopsy reveals invasive
ductal carcinoma with overexpression of HER2/neu (ERBB2). Which targeted therapy mechanism is most
appropriate?
, A. Selective estrogen receptor modulation
B. Inhibition of HER2 tyrosine kinase receptor signaling
C. Blockade of vascular endothelial growth factor (VEGF)
D. Inhibition of cyclin-dependent kinases 4 and 6. [CORRECT]
Correct Answer: B
Rationale: HER2/neu (ERBB2) is a transmembrane tyrosine kinase receptor that drives cellular
proliferation, survival, and angiogenesis when overexpressed. Trastuzumab (Herceptin) is a monoclonal
antibody that binds the extracellular domain of HER2, preventing receptor dimerization and
downstream PI3K/AKT and RAS/MAPK signaling pathways, thereby inhibiting tumor growth and
promoting antibody-dependent cellular cytotoxicity. [CORRECT]
Q6: A patient with metastatic melanoma is treated with pembrolizumab. Which cellular mechanism
does this drug target?
A. Inhibition of BRAF V600E mutation
B. Blockade of programmed cell death protein 1 (PD-1)
C. Inhibition of MEK1/2 kinases
D. Blockade of cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). [CORRECT]
Correct Answer: B
Rationale: Pembrolizumab is a humanized monoclonal antibody that blocks the interaction between PD-
1 on T cells and its ligands PD-L1/PD-L2 on tumor cells. This checkpoint inhibition prevents T-cell
exhaustion and restores antitumor immunity, allowing cytotoxic T cells to recognize and kill melanoma
cells expressing tumor antigens. [CORRECT]
Q7: A patient with small cell lung cancer (SCLC) is treated with cisplatin and etoposide. Cisplatin exerts
its cytotoxic effect primarily through:
A. Inhibition of thymidylate synthase
B. Formation of DNA cross-links and activation of apoptotic pathways
C. Inhibition of microtubule polymerization
D. Blockade of androgen receptor signaling. [CORRECT]
Correct Answer: B
Rationale: Cisplatin is a platinum-based alkylating agent that enters cells through copper transporters,
becomes aquated in the cytoplasm, and forms covalent cross-links between adjacent guanine residues
in DNA. These intrastrand and interstrand cross-links block DNA replication and transcription, triggering
